Characteristics and outcomes of patients with recurrent ovarian cancer undergoing early phase immune checkpoint inhibitor clinical trialsEmily Hinchcliff, Amir A. Jazaeri, Hung Le et al.|Gynecologic Oncology|2018Cited by 31